OmK2 Retinacit sterile eye solution, diabetic retinopathy treatment Composition:

Citicoline monosodium salt, cyanocobalamin (vitamin B12), hyaluronic acid, monobasic sodium phosphate monohydrate, dibasic sodium phosphate dodecahydrate, sodium chloride, benzalkonium chloride, water for injection.

Action:
In Retinacit OmK2 sterile eye solution, citicoline 2%, high molecular weight hyaluronic acid 0.2% and vitamin B12 were used. Due to the content of citicoline, drops are recommended for use in patients at the initial stage of diabetic retinopathy. Citicoline supports the process of restoring the integrity of cell membranes that have been damaged as a result of degenerative pathological changes in the eye. In addition, hyaluronic acid promotes the regeneration of the eye surface, because it creates optimal conditions for this. Vitamin B12 (cyanocobalamin) protects against the harmful effects of free radicals, and also contributes to the growth of corneal epithelial cells.

OmK2 Retinacit sterile eye solution, diabetic retinopathy treatment Application:

Medical device Retinacit OmK2 sterile ophthalmic solution designed to be used for moisturizing and nourishing the eyes, recommended for people in the initial stage of diabetic retinopathy.

Additional information:
Keep the product out of reach of children at room temperature.

Contraindications:
Do not use in the case of hypersensitivity to any component of eye drops.

Directions for use OmK2 Retinacit sterile eye solution, diabetic retinopathy treatment:

It is recommended to apply one drop to each eye three times a day.